H.R. 8269 · 119th Congress · Commerce
CLEAR LABELS Act
- IntroducedApr 14, 2026 Done
- CommitteeReferred to 2 committees Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.Who lobbies on it
6 organizations, more than 94% of House bills · 11 filings · Q2 2026–Q3 2026One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Pharmaceutical Research and Manufacturers of America
2 of 2 quarters
“…H.R. 8269: CLEAR LABELS Act H.R. 9599: SECURE 340B Act H.R. 9661: Expedited Access to Biosimilars Act 340B Drug Pricing Integrity and Affordability for Patients Act (draft) SECURE Act of 2026 (draft) Biopharmaceutical innovation policy issues User fee issues Vaccine policy issues Inflation Reduction Act of 2022…”
$26.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing
-
Association for Accessible Medicines
2 of 2 quarters
“…H.R.8269/S.3788: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act. American Made Medicines Act. PBM Bid Transparency. S.4280: Security And Freedom Enhancement Act of 2026 (SAFE) Act.”
$2.5M lobbying spend in 2026 to date, all issuesQ3 2026 filing
-
National Community Pharmacists Association
2 of 2 quarters
“…S.3788/H.R.8269, the CLEAR LABELS Act; S.1941, the Cure Hepatitis C Act of 2025; Comments to Senate Finance "Re: Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients"; H.R. 8630, the PEAT Act; Comments to HHS, ASPE on "RE: Docket No. HHS-OS-2026-0332 for Request for Information…”
$960K lobbying spend in 2026 to date, all issuesQ3 2026 filing
3 more organizations, every filingPROUpgrade
Organizations that named H.R. 8269 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Apr 14, 2026Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 14, 2026Introduced in House
What members said about it
-
A Look into Congressman Fuller’s Legislative Portfolio
From the moment he joined Congress, Representative Fuller has supported legislation addressing key constituent priorities, including job creation, border security, energy policy, fiscal responsibility, support for law enforcement, standing…
“Since the day I was elected, I made a promise to the hardworking people of Northwest Georgia that I would be a fighter. Each and every day that I am here in Washington, I will put the best interests of my constituents first. I will continue working to advance legislation that puts Faith, Duty, and America First.”